Trabectedin plus durvalumab in patients with advanced pretreated soft tissue sarcoma and ovarian carcinoma (TRAMUNE): an open-label, multicenter phase Ib study

Overview of attention for article published in Clinical Cancer Research, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs: 1 blog
twitter: 25 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 11 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Trabectedin plus Durvalumab in Advanced Pretreated Soft Tissue Sarcoma

Physician's Weekly, 09 Jun 2022

For a study, researchers sought to understand that TRAMUNE was a phase Ib study that combines trabectedin with durvalumab and…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.